Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meredith M Regan

Showing results (21-30 of 259) with videos related to

Pageof 26
Sort By:
Cancer|October 26, 2007
Higher prostate-specific antigen levels predict improved survival in patients with hormone-refractory prostate cancer who have skeletal metastases and normal serum alkaline phosphataseWanling Xie, Mari Nakabayashi, Meredith M Regan, et al.
Cancer|April 25, 2003
Physician attitudes toward cytotoxic chemotherapy use in patients with advanced prostate carcinomaWilliam K Oh, Patrice Tully, Philip W Kantoff, et al.
Fertility and Sterility|March 24, 2004
Initiation of the gonadotropin-releasing hormone antagonist ganirelix for in vitro fertilization cycles in which the lead follicle is >14 mmSigal Klipstein, Richard H Reindollar, Meredith M Regan, et al.
The Journal of Nutrition|December 21, 2005
Branched-chain amino acid requirements in healthy adult human subjectsAnura V Kurpad, Meredith M Regan, Tony Raj, et al.
Cancer Journal (Sudbury, Mass.)|May 4, 2007
Response to vinorelbine with or without estramustine as second-line chemotherapy in patients with hormone-refractory prostate cancerMari Nakabayashi, Jonathan Ling, Wanling Xie, et al.
Anesthesia and Analgesia|March 26, 2004
Inotropes improve right heart function in patients undergoing aortic valve replacement for aortic stenosisAndrew D Maslow, Meredith M Regan, Carl Schwartz, et al.
The Journal of Urology|March 7, 2006
Low age adjusted free testosterone levels correlate with poorly differentiated prostate cancerIgnacio F San Francisco, Meredith M Regan, William C Dewolf, et al.
Clinical Genitourinary Cancer|June 25, 2013
Dramatic and prolonged PSA response after retreatment with a PSA vaccineAdam Rojan, Renee Funches, Meredith M Regan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 28, 2019
Adjuvant Systemic Treatment of Premenopausal Women With Hormone Receptor-Positive Early Breast Cancer: Lights and ShadowsMeredith M Regan, Gini F Fleming, Barbara Walley, et al.
The Journal of Urology|March 17, 2004
Percent of cores positive for cancer is a better preoperative predictor of cancer recurrence after radical prostatectomy than prostate specific antigenIgnacio F San Francisco, Meredith M Regan, Aria F Olumi, et al.
Pageof 26

Showing results (21-30 of 259) with videos related to

Sort By:
Pageof 26
Cancer|October 26, 2007
Higher prostate-specific antigen levels predict improved survival in patients with hormone-refractory prostate cancer who have skeletal metastases and normal serum alkaline phosphataseWanling Xie, Mari Nakabayashi, Meredith M Regan, et al.
Cancer|April 25, 2003
Physician attitudes toward cytotoxic chemotherapy use in patients with advanced prostate carcinomaWilliam K Oh, Patrice Tully, Philip W Kantoff, et al.
Fertility and Sterility|March 24, 2004
Initiation of the gonadotropin-releasing hormone antagonist ganirelix for in vitro fertilization cycles in which the lead follicle is >14 mmSigal Klipstein, Richard H Reindollar, Meredith M Regan, et al.
The Journal of Nutrition|December 21, 2005
Branched-chain amino acid requirements in healthy adult human subjectsAnura V Kurpad, Meredith M Regan, Tony Raj, et al.
Cancer Journal (Sudbury, Mass.)|May 4, 2007
Response to vinorelbine with or without estramustine as second-line chemotherapy in patients with hormone-refractory prostate cancerMari Nakabayashi, Jonathan Ling, Wanling Xie, et al.
Anesthesia and Analgesia|March 26, 2004
Inotropes improve right heart function in patients undergoing aortic valve replacement for aortic stenosisAndrew D Maslow, Meredith M Regan, Carl Schwartz, et al.
The Journal of Urology|March 7, 2006
Low age adjusted free testosterone levels correlate with poorly differentiated prostate cancerIgnacio F San Francisco, Meredith M Regan, William C Dewolf, et al.
Clinical Genitourinary Cancer|June 25, 2013
Dramatic and prolonged PSA response after retreatment with a PSA vaccineAdam Rojan, Renee Funches, Meredith M Regan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 28, 2019
Adjuvant Systemic Treatment of Premenopausal Women With Hormone Receptor-Positive Early Breast Cancer: Lights and ShadowsMeredith M Regan, Gini F Fleming, Barbara Walley, et al.
The Journal of Urology|March 17, 2004
Percent of cores positive for cancer is a better preoperative predictor of cancer recurrence after radical prostatectomy than prostate specific antigenIgnacio F San Francisco, Meredith M Regan, Aria F Olumi, et al.
Pageof 26